Article Information
History
- March 6, 2020.
Article Versions
- Version 1 (February 21, 2020 - 21:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Intikhab alam1,*,
- Allan Kamau1,
- Maxat Kulmanov1,
- Stefan T. Arold1,2,
- Arnab Pain3,4,
- Takashi Gojobori1 and
- Carlos M. Duarte1,*
- 1King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Biological and Environmental Science and Engineering (BESE), Thuwal, 23955-6900, Saudi Arabia
- 2Centre de Biochimie Structurale, CNRS, INSERM, Université de Montpellier, 34090 Montpellier, France
- 3Biological and Environmental Science and Engineering (BESE), Thuwal, 23955-6900, Saudi Arabia
- 4Research Center for Zoonosis Control, Hokkaido University, Sapporo, 001-0020 Japan
- ↵*corresponding authors: Intikhab.Alam{at}kaust.edu.sa, Carlos.Duarte{at}kaust.edu.sa
Posted March 06, 2020.
Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019
